Esterilloss

Esteriloss is a product designed to help women and their healthcare providers with postpartum tubal ligation reversal. The product is marketed as a minimally invasive solution for women who undergo tubal ligation but later decide they wish to become pregnant again.

The Esteriloss system consists of a device and a kit containing a syringe and other instruments. The device is inserted into the fallopian tube and works to dissolve the clips or rings used to occlude the tube. This process is typically done under sedation or local anesthesia and can be performed in a clinical setting.

The Esteriloss procedure is not a traditional surgical procedure but rather a specialized minimally invasive technique. The device is designed to be inserted and removed within a short period, often lasting less than an hour. The exact success rate of the Esteriloss procedure varies, but multiple clinical studies have reported high rates of successful reversal, in many cases up to 90%.

While Esteriloss may be a viable option for women who have undergone tubal ligation and wish to reverse the procedure, it is essential to note that not all cases may be suitable for the product. The success of the procedure and the overall health of the individual patient will determine if the Esteriloss system can be used. As with any medical treatment, potential risks and complications should be evaluated closely before proceeding with the Esteriloss procedure.